CO-IRBESARTAN Sandoz cpr pell 150/12.5 mg 28 pce

7680626400014 CH-62640 C09DA04 02.07.2.
CO-IRBESARTAN Sandoz cpr pell 150/12.5 mg 28 pce
CO-IRBESARTAN Sandoz cpr pell 150/12.5 mg 28 pce
1 / 2
google

Details

Product number
6264001
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
irbesartanum 150 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 8 mg, carmellosum natricum conexum corresp. natrium 0.595 mg, silica colloidalis anhydrica, hypromellosum, cellulosum microcristallinum silicificatum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 6000, lactosum monohydricum 0.252 mg, talcum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto.

Articles (1)

Co-Irbesartan Sandoz 150/12,5 mg, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/08/2025
Patient information leaflet
Français
21/08/2025
Patient information leaflet
Italien
21/08/2025
Professional SmPC
Allemand
21/08/2025
Professional SmPC
Français
21/08/2025
Professional SmPC
Italien
21/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
12.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
8.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
0.595 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.252 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 26.50
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2014

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
62640
Drug name
Co-Irbesartan Sandoz, Filmtabletten
Galenic form
FILM
ATC Code
C09DA04
Authorization status
Z
Dispensation category
B
First authorization
06/11/2012
Authorization expiration date
31/12/9999
IT number
02.07.2.
Domain
Human medicine
Field of application
Essentielle Hypertonie

Packaging details

Description (FR)
CO-IRBESARTAN Sandoz cpr pell 150/12.5 mg 28 pce
Description (DE)
CO-IRBESARTAN Sandoz Filmtabl 150/12.5 mg 28 Stk
Market launch
06/11/2012
Narcotic (BTM)
No

Original drug

CoAprovel, comprimés filmés
CHF 27.45
View original

Other packaging sizes

CO-IRBESARTAN Sandoz cpr pell 150/12.5 mg 98 pce
98 TABL
View
CO-IRBESARTAN Sandoz cpr pell 300/12.5 mg 28 pce
28 TABL
View
CO-IRBESARTAN Sandoz cpr pell 300/12.5 mg 98 pce
98 TABL
View
CO-IRBESARTAN Sandoz cpr pell 300/25 mg 28 pce
28 TABL
View
CO-IRBESARTAN Sandoz cpr pell 300/25 mg 98 pce
98 TABL
View